The stock collapsed 12 percent in a single day on one report.
When a short seller's report accused Blaize Holdings of fabricating a $50 million business deal in late April 2026, the market rendered its verdict swiftly — shares fell 12 percent in a single session, and the losses have not stopped there. Now, as the stock drifts near $1.47, the Rosen Law Firm has stepped in to investigate whether the company's public disclosures were materially deceptive, offering shareholders a collective path toward accountability. It is a familiar arc in the life of markets: a moment of alleged concealment, a sudden reckoning, and then the slow, institutional work of determining what was true.
- A short seller's fraud allegation against Blaize Holdings erased 12% of the company's stock value in a single trading day on April 28, 2026, sending shockwaves through its investor base.
- The central accusation — that Blaize's $50 million NeoTensr deal was fabricated — has not been independently verified, but it was damaging enough to trigger both a market collapse and a formal legal investigation.
- Blaize's stock has continued bleeding since the initial drop, reaching $1.47 per share by June 17, compounding losses for shareholders who bought in at higher prices.
- The Rosen Law Firm, citing a top-four ranking in securities settlements every year since 2013, is now recruiting affected investors into a class action lawsuit at no upfront cost.
- The investigation hinges on whether Blaize misled investors in its public disclosures — a legal question that could determine whether shareholders recover any of what they lost.
In late April 2026, a short seller called Pelican Way Research published a report alleging that Blaize Holdings, a NASDAQ-listed company trading as BZAI, had fabricated a $50 million agreement with a partner known as NeoTensr. The market reacted immediately: on April 28, Blaize's stock fell 12 percent in a single session, wiping out substantial shareholder value and raising urgent questions about the company's integrity.
Nearly two months later, the Rosen Law Firm — a New York practice specializing in investor protection — announced a formal investigation into whether Blaize misled the public about its financial dealings. The firm is recruiting shareholders into a class action lawsuit, a legal structure that allows many investors to pool their claims into one case. Participation carries no upfront cost; attorneys are paid only from any eventual settlement or judgment.
The legal question at the heart of the investigation is whether Blaize's disclosures about the NeoTensr transaction were materially misleading — false or incomplete in ways that would have influenced investor decisions. Pelican Way's specific fraud claims remain unverified, but they proved damaging enough to set off both a market collapse and a formal inquiry.
Rosen Law Firm brings considerable experience to the case, having ranked among the top four firms for securities class action settlements every year since 2013 and recovering $438 million for investors in 2019 alone. The firm's message to shareholders is direct: collective legal action exists precisely because individual investors rarely have the resources to challenge a public company alone.
As of June 17, 2026, Blaize shares were trading at $1.47 — down more than 5 percent from the prior session and far below where many investors entered their positions. For those shareholders, the losses are real, ongoing, and now the subject of a legal process that may determine whether anyone is held responsible.
In mid-April, a short seller named Pelican Way Research published a report questioning the legitimacy of a major business deal at Blaize Holdings, a company trading on the NASDAQ under the ticker BZAI. The report alleged that a $50 million agreement between Blaize and a partner called NeoTensr was fraudulent. Within hours of the allegation hitting the market on April 28, 2026, Blaize's stock price collapsed by 12 percent. That single day of trading wiped out billions in shareholder value and set off alarm bells among investors who had bet on the company's future.
Now, nearly two months later, the Rosen Law Firm—a New York-based practice that specializes in investor protection—is formally investigating whether Blaize misled the public about its financial condition and business dealings. The firm is recruiting shareholders to join a class action lawsuit, a legal mechanism that pools the claims of many investors into a single case. Anyone who bought Blaize securities during the relevant period may be eligible to recover losses. The firm is taking the case on a contingency basis, meaning investors pay nothing upfront and only contribute a portion of any settlement or judgment they receive.
The investigation centers on whether Blaize's public disclosures about the NeoTensr transaction were materially misleading—that is, whether the company told investors things that were false or incomplete in ways that would have mattered to their investment decisions. Short sellers, who profit when stock prices fall, sometimes publish research that turns out to be accurate and sometimes publish research that is wrong or exaggerated. Pelican Way Research's specific claims about fraud in the NeoTensr deal have not been independently verified, but they were damaging enough to trigger a sharp market reaction and now a formal legal inquiry.
Rosen Law Firm has positioned itself as an experienced hand in this arena. The firm notes that it has ranked in the top four for securities class action settlements every year since 2013, and in 2017 it held the number one ranking by ISS Securities Class Action Services. The firm's attorneys have recovered hundreds of millions of dollars for investors over the years—$438 million in 2019 alone. Founding partner Laurence Rosen was named a Titan of the Plaintiffs' Bar by Law360 in 2020. The firm's message to investors is straightforward: if you lost money on Blaize, you should consider joining the case, and you should choose a lawyer with a proven track record.
By mid-June, when the investigation was announced, Blaize's stock had continued its downward drift. The company was trading at $1.47 per share on June 17, 2026, down more than 5 percent from the previous trading session. That represents a steep decline from wherever the stock was trading before the Pelican Way report, though the exact pre-report price is not specified in the available information. For investors who bought at higher prices, the losses are real and accumulating.
The class action mechanism exists precisely for situations like this: when a company's alleged misconduct harms many small investors, pooling their claims makes it economically viable to pursue justice. Individual investors might not have the resources to sue a public company on their own, but together they can hire experienced counsel and mount a credible legal challenge. Rosen Law Firm is inviting Blaize shareholders to contact them through their website, by phone, or by email to learn more about joining the prospective lawsuit. The firm has handled thousands of such cases and knows the terrain well.
Citações Notáveis
If you purchased Blaize securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.— Rosen Law Firm
A Conversa do Hearth Outra perspectiva sobre a história
What exactly did Pelican Way Research claim about the NeoTensr deal?
They alleged it was fraudulent—that the $50 million transaction wasn't what Blaize had told investors it was. The specifics of their allegations aren't detailed in the public record I'm looking at, but the claim was serious enough to spook the market immediately.
And Blaize's stock dropped 12 percent in a single day because of one report from a short seller?
Yes. That's how markets work sometimes. A credible-sounding allegation from a research firm, especially one that has skin in the game by shorting the stock, can trigger a cascade. Other investors start selling, algorithms kick in, and suddenly the price is down sharply. Whether the allegation is ultimately true is a separate question.
So Rosen Law Firm doesn't know yet if Blaize actually misled anyone?
Correct. They're investigating. They're saying that if Blaize's public statements about the deal were materially misleading—if they left out important facts or told outright falsehoods—then shareholders have a claim. But the investigation is ongoing. The lawsuit hasn't been filed yet; they're still recruiting investors.
Why would investors join a class action if they don't know if they'll win?
Because the alternative is to absorb the loss alone. In a class action, you're pooling resources with other investors to hire experienced lawyers who can actually afford to investigate and litigate. And you only pay if you recover something. It's a way to make it worth someone's time to fight on your behalf.
What's Rosen's angle here? Why are they so eager to take this case?
They make money if they win. They take a percentage of any settlement or judgment. But they've built a reputation by winning these cases consistently—top four rankings for years, hundreds of millions recovered. Their credibility is their business. They're not going to chase frivolous claims.
So what happens next?
Investors contact Rosen, provide evidence of their purchases, and join the class. Rosen files the lawsuit, discovery happens, and either the case settles or goes to trial. Meanwhile, Blaize's stock price will probably continue to reflect the market's loss of confidence. The company will either defend itself or negotiate a settlement.